During the past three years and after the chaotic decisions to vaccinate millions of patients world-wide, some common sense and scientific results are now appearing in the literature.
Thanks to Peter McCullogh MD and Robert Malone M.D. The issues were brought to light and they continue their very significant dedication toward promulgating the truth.
Many opinions and papers were printed in the early phases of the pandmic. Even the FDA has been compromised by shills previously employed by PHARMA
Fact check: Some, but not all, of FDA's funding comes from the companies whose products it approves.
On Aug. 23, the U.S. Food and Drug Administration announced full approval of the Pfizer-BioNTech COVID-19 vaccine. The green light comes eight months after the vaccine received emergency use authorization, a swiftness which has some social media users crying foul.
"Did you know that the FDA receives the majority of its drug regulatory budget from the same companies they are supposed to regulate? Conflict of interest?"
About 45% of the FDA's budget, or $2.7 billion, comes from industry user fees, according to a fact sheet released by the FDA in November 2020. The other 55%, or $3.2 billion, comes from federal funding.
A further breakdown of the agency's total budget does show, depending on the department, industry fees can account for most of the funding, however.
For regulatory activities involving human drugs (which account for a third of the agency's total budget), 65%, or about $656 million, is funded by industry user fees.
For biologics, which includes vaccines and represents 7% of the FDA's total budget, industry fees pay about 40%, or around $337 million.
While there is a concern industry-based funding – which increased nearly 42% between the fiscal years 2017 and 2021 – may pose a conflict of interest, the FDA has said its drug approval decisions are independent of where the funding comes.
In the interest of fairness and transparency, the FDA explains;
Fees are collected when drugmakers apply for approval and pay for the drug's review process, but they do not influence the outcome of the approval decision, according to the FDA. Those fees make up 45% of the FDA's overall budget, but they do comprise a majority of the funding for the subsection of the agency that handles drug approvals.
Gary’s Newletter reports, you decide.
While I actually support industry paying for the "costs" of review by the FDA, the potential for corruption is real. The lack of information about the risks of the vaccines, released under emergency authority when it appeared the Covid virus was highly lethal, itself a judgement based on bad data, and the different nature of the vaccine, were unlike anything before. The public deserved a rapid publication of more accurate information on a regular basis. The condemnation of those who found and wished to alert the public to the problems was a distortion of the responsibilites of several organizations and the people in charge of them, Fauci being the principal agent. There continue to be attempts to shut down opposition to the "vaccines" and to deflect the dangers associated with them. I suspect it will be decades, not years, before the "facts" are known with sufficient confidence, clearly too late to help with the current ones, but perhaps not for attempts to circumvent a proper development of therapies and more importantly the dissemination of information which each of us can use according to our own judgement.